Skip to content

Released Sep 7, 2018, after the close

10-Q filed Sep 10, 2018, 72 days after period end · 0001213900-18-012298

Q2 2018 · 10-Q
Revenue—
Net Income-$1.79MN/M vs Q2 2017N/M vs Q1 2018
EPS Diluted-$0.50N/M vs Q2 2017N/M vs Q1 2018
Operating Income-$1,741,467N/M
Operating Cash Flowderived-$188,940—

What the release said

No earnings release is on file for this quarter. Its figures came with the 10-Q.

Same quarter

MetricQ2 2018Q2 2017
Net Income-$1.79M-$264.27K
EPS Diluted-$0.50-$0.08

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

Azora Therapeutics, Inc. (DE) · CIK 1513525 · Engraved from SEC EDGAR